相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells
Leah Fitzsimmons et al.
CELL DEATH AND DIFFERENTIATION (2018)
Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review
Joana Ribeiro et al.
FUTURE ONCOLOGY (2017)
Vaccinia virus evasion of regulated cell death
David L. Veyer et al.
IMMUNOLOGY LETTERS (2017)
Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences
Yasin Kaymaz et al.
MOLECULAR CANCER RESEARCH (2017)
KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage
Laura Castellini et al.
NUCLEIC ACIDS RESEARCH (2017)
Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus
Wolfram Brune et al.
VIRUSES-BASEL (2017)
Epstein-Barr virus particles induce centrosome amplification and chromosomal instability
Anatoliy Shumilov et al.
NATURE COMMUNICATIONS (2017)
CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors
Yijie Ma et al.
CELL HOST & MICROBE (2017)
Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma
Teresa Amato et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis
Hyoji Kim et al.
JOURNAL OF VIROLOGY (2016)
Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle
Luke R. Williams et al.
JOURNAL OF VIROLOGY (2016)
Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins
Paulo H. C. Godoi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains
Teru Kanda et al.
JOURNAL OF VIROLOGY (2016)
Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization
Karyn McFadden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Downregulation of Smurf2 ubiquitin ligase in pancreatic cancer cells reversed TGF-β-induced tumor formation
Bo Wu et al.
TUMOR BIOLOGY (2016)
Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response
Joshua T. Burgess et al.
CELL DEATH & DISEASE (2016)
A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog
Katharina Bernhardt et al.
PLOS PATHOGENS (2016)
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs
C. David Wood et al.
ELIFE (2016)
Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing
Lijuan Hu et al.
FRONTIERS OF MEDICINE (2016)
Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells
H. M. Kofahi et al.
SCIENTIFIC REPORTS (2016)
Epstein-Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production and B Lymphoma Cell Survival
A. Harris-Arnold et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations
Anais Pujals et al.
AUTOPHAGY (2015)
Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins
Glenna Wink Foight et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas
Riccardo Dolcetti
SEMINARS IN CANCER BIOLOGY (2015)
Unexpected patterns of Epstein-Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA
Rosemary J. Tierney et al.
VIROLOGY (2015)
Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
Rachel Hood Edwards et al.
MBIO (2015)
EBNA3C regulates p53 through induction of Aurora kinase B
Hem C. Jha et al.
ONCOTARGET (2015)
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
Francesco Abate et al.
PLOS PATHOGENS (2015)
Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2
Genaro Pimienta et al.
PLOS ONE (2015)
Repression of the Proapoptotic Cellular BIK/NBK Gene by Epstein-Barr Virus Antagonizes Transforming Growth Factor β1-Induced B-Cell Apoptosis
Eva M. Campion et al.
JOURNAL OF VIROLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Epstein-Barr virus maintains lymphomas via its miRNAs
D. T. Vereide et al.
ONCOGENE (2014)
Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest
Pavel A. Nikitin et al.
PLOS ONE (2014)
Epstein-Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A
Sizun Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The NF-κB Genomic Landscape in Lymphoblastoid B Cells
Bo Zhao et al.
CELL REPORTS (2014)
Epstein-Barr virus and Burkitt lymphoma
Martin Rowe et al.
CHINESE JOURNAL OF CANCER (2014)
Syk-Induced Phosphatidylinositol-3-Kinase Activation in EpsteinBarr Virus Posttransplant Lymphoproliferative Disorder
O. Hatton et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Genome-wide analyses of Epstein-Barr virus reveal conserved RNA structures and a novel stable intronic sequence RNA
Walter N. Moss et al.
BMC GENOMICS (2013)
Early growth response protein 1 upregulation and nuclear translocation by 2′-benzoyloxycinnamaldehyde induces prostate cancer cell death
Hye-Sook Kang et al.
CANCER LETTERS (2013)
Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases
Michele Bernasconi et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Transforming Growth Factor-β Directly Induces p53-up-regulated Modulator of Apoptosis (PUMA) during the Rapid Induction of Apoptosis in Myc-driven B-cell Lymphomas
Lindsay C. Spender et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Autocrine CCL3 and CCL4 Induced by the Oncoprotein LMP1 Promote Epstein-Barr Virus-Triggered B Cell Proliferation
Shu-Chun Tsai et al.
JOURNAL OF VIROLOGY (2013)
A Cluster of Virus-Encoded MicroRNAs Accelerates Acute Systemic Epstein-Barr Virus Infection but Does Not Significantly Enhance Virus-Induced Oncogenesis In Vivo
Angela Wahl et al.
JOURNAL OF VIROLOGY (2013)
MicroRNA target site identification by integrating sequence and binding information
William H. Majoros et al.
NATURE METHODS (2013)
Epstein-Barr Virus Infection and Altered Control of Apoptotic Pathways in Posttransplant Lymphoproliferative Disorders
Maria-Rosa Ghigna et al.
PATHOBIOLOGY (2013)
NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
Ina Ersing et al.
VIRUSES-BASEL (2013)
Replication of Epstein-Barr Viral DNA
Wolfgang Hammerschmidt et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Structural biology of the Bcl-2 family and its mimicry by viral proteins
M. Kvansakul et al.
CELL DEATH & DISEASE (2013)
Expression of c-myc and PCNA in Epstein-Barr virus-associated gastric carcinoma
Shiguang Zhu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Correction: Induction of p16INK4aIs the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
Lenka Skalska et al.
PLoS Pathogens (2013)
Modulation of Enhancer Looping and Differential Gene Targeting by Epstein-Barr Virus Transcription Factors Directs Cellular Reprogramming
Michael J. McClellan et al.
PLOS PATHOGENS (2013)
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex
Rocco Piazza et al.
NEOPLASIA (2013)
Epigenetic control of Epstein–Barr virus transcription – relevance to viral life cycle?
Alison J. Sinclair
Frontiers in Genetics (2013)
Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Ian Magrath
BRITISH JOURNAL OF HAEMATOLOGY (2012)
EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency
Kasandra J. Riley et al.
EMBO JOURNAL (2012)
Identification of New Viral Genes and Transcript Isoforms during Epstein-Barr Virus Reactivation using RNA-Seq
Monica Concha et al.
JOURNAL OF VIROLOGY (2012)
Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF-κB Activation
Alexander M. Price et al.
JOURNAL OF VIROLOGY (2012)
The Latent Membrane Protein 1 (LMP1) Oncogene of Epstein-Barr Virus Can Simultaneously Induce and Inhibit Apoptosis in B Cells
Zachary L. Pratt et al.
JOURNAL OF VIROLOGY (2012)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
The genetic landscape of mutations in Burkitt lymphoma
Cassandra Love et al.
NATURE GENETICS (2012)
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing
Julia Richter et al.
NATURE GENETICS (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
Kostas Paschos et al.
NUCLEIC ACIDS RESEARCH (2012)
Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation
Eveline K. Hoebe et al.
VIRAL IMMUNOLOGY (2012)
Contributions of Epstein-Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
Lori Frappier
VIRUSES-BASEL (2012)
BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
Anne Woellmer et al.
PLOS PATHOGENS (2012)
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Rebecca L. Skalsky et al.
PLOS PATHOGENS (2012)
Lymphomas differ in their dependence on Epstein-Barr virus
David T. Vereide et al.
BLOOD (2011)
Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas
Katerina Vrzalikova et al.
BLOOD (2011)
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Andreas Strasser et al.
EMBO JOURNAL (2011)
Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53
Elena Kashuba et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells
Jonathan L. Coloff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The BTB and CNC Homology 1 (BACH1) Target Genes Are Involved in the Oxidative Stress Response and in Control of the Cell Cycle
Hans-Joerg Warnatz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation
Richard Amoroso et al.
JOURNAL OF VIROLOGY (2011)
EBNA3C Attenuates the Function of p53 through Interaction with Inhibitor of Growth Family Proteins 4 and 5
Abhik Saha et al.
JOURNAL OF VIROLOGY (2011)
The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes
Regina Feederle et al.
JOURNAL OF VIROLOGY (2011)
Epstein-Barr Virus BamHI W Repeat Number Limits EBNA2/EBNA-LP Coexpression in Newly Infected B Cells and the Efficiency of B-Cell Transformation: a Rationale for the Multiple W Repeats in Wild-Type Virus Strains
Rosemary J. Tierney et al.
JOURNAL OF VIROLOGY (2011)
Cellular Gene Expression That Correlates with EBER Expression in Epstein-Barr Virus-Infected Lymphoblastoid Cell Lines
Goran Gregorovic et al.
JOURNAL OF VIROLOGY (2011)
Canonical NF-κB Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation
Benjamin E. Gewurz et al.
JOURNAL OF VIROLOGY (2011)
Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression
Jade Yee et al.
PLOS ONE (2011)
Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression
Seiji Maruo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin
Jie Lu et al.
VIROLOGY (2011)
The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim
Aron R. Marquitz et al.
VIROLOGY (2011)
A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus
Regina Feederle et al.
PLOS PATHOGENS (2011)
Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2
Jianmin Zuo et al.
PLOS PATHOGENS (2011)
Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
Qiliang Cai et al.
PLOS PATHOGENS (2011)
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy
Christopher P. Fox et al.
BLOOD (2010)
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
Lina Happo et al.
BLOOD (2010)
Genome wide DNA-profiling of HIV-related B-cell lymphomas
Daniela Capello et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Epstein-Barr virus in Burkitt's lymphoma A role for latent membrane protein 2A
Kathryn T. Bieging et al.
CELL CYCLE (2010)
Systematic Analysis of Viral and Cellular MicroRNA Targets in Cells Latently Infected with Human γ-Herpesviruses by RISC Immunoprecipitation Assay
Lars Doelken et al.
CELL HOST & MICROBE (2010)
An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells
Pavel A. Nikitin et al.
CELL HOST & MICROBE (2010)
Epstein-Barr Virus-Encoded Bcl-2 Homologue Functions as a Survival Factor in Wp-Restricted Burkitt Lymphoma Cell Line P3HR-1
Ami Watanabe et al.
JOURNAL OF VIROLOGY (2010)
Quantitative and Qualitative RNA-Seq-Based Evaluation of Epstein-Barr Virus Transcription in Type I Latency Burkitt's Lymphoma Cells
Zhen Lin et al.
JOURNAL OF VIROLOGY (2010)
Epstein-Barr Virus Latent Membrane Protein 1 Modulates Distinctive NF-κB Pathways through C-Terminus-Activating Region 1 To Regulate Epidermal Growth Factor Receptor Expression
Che-Pei Kung et al.
JOURNAL OF VIROLOGY (2010)
Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing
Shu-Jen Chen et al.
PLOS ONE (2010)
AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome
Markus Kalla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)
Fang Lu et al.
VIROLOGY JOURNAL (2010)
Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus BHRF1
Marc Kvansakul et al.
PLOS PATHOGENS (2010)
Epigenetic Repression of p16(INK4A) by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
Lenka Skalska et al.
PLOS PATHOGENS (2010)
Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells
Eri Seto et al.
PLOS PATHOGENS (2010)
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
E. M. Michalak et al.
CELL DEATH AND DIFFERENTIATION (2009)
Comparative analysis of the Epstein-Barr virus encoded nuclear proteins of EBNA-3 family
Surya Pavan Yenamandra et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2009)
p16INK4A Sensitizes Human Leukemia Cells to FAS- and Glucocorticoid-induced Apoptosis via Induction of BBC3/Puma and Repression of MCL1 and BCL2
Petra Obexer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Epstein-Barr virus BART gene expression
Maha Al-Mozaini et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Identifying Sites Bound by Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) in the Human Genome: Defining a Position-Weighted Matrix To Predict Sites Bound by EBNA1 in Viral Genomes
Lindsay R. Dresang et al.
JOURNAL OF VIROLOGY (2009)
MDM2-Dependent Inhibition of p53 Is Required for Epstein-Barr Virus B-Cell Growth Transformation and Infected-Cell Survival
Eleonora Forte et al.
JOURNAL OF VIROLOGY (2009)
Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2
Abhik Saha et al.
JOURNAL OF VIROLOGY (2009)
Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification
Claire Shannon-Lowe et al.
JOURNAL OF VIROLOGY (2009)
Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas
Jia Yun Zhu et al.
JOURNAL OF VIROLOGY (2009)
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps
Sung Wook Chi et al.
NATURE (2009)
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints
B. Gruhne et al.
ONCOGENE (2009)
EBNA1 regulates cellular gene expression by binding cellular promoters
Allon Canaan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
Kathryn T. Bieging et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim
Anthony L. Desbien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species
Bettina Gruhne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia
Hans Helmut Niller et al.
SEMINARS IN CANCER BIOLOGY (2009)
Proof for EBV's sustaining role in Burkitt's lymphomas
David Vereide et al.
SEMINARS IN CANCER BIOLOGY (2009)
The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines
Zachary L. Pratt et al.
VIROLOGY (2009)
Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent
Lassad Oussaief et al.
VIROLOGY (2009)
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities
Fuming Yi et al.
VIROLOGY (2009)
The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53
Arnold J. Levine
VIROLOGY (2009)
Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
Marie L. Hertle et al.
PLOS PATHOGENS (2009)
Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim
Kostas Paschos et al.
PLOS PATHOGENS (2009)
An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link
Gemma L. Kelly et al.
PLOS PATHOGENS (2009)
Burkitt Lymphoma in Brazil Is Characterized by Geographically Distinct Clinicopathologic Features
Eduardo M. Queiroga et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3
Tianli Xia et al.
CANCER RESEARCH (2008)
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival
Elizabeth Yee-Wai Choy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn
Mark Rovedo et al.
JOURNAL OF VIROLOGY (2008)
Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency IIIB cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis
Christophe Le Clorennec et al.
JOURNAL OF VIROLOGY (2008)
Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing
Rachel Hood Edwards et al.
JOURNAL OF VIROLOGY (2008)
Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis
Sean P. Garrison et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax
Jamie I. Fletchera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural plasticity underpins promiscuous binding of the prosurvival protein a1
Callum Smits et al.
STRUCTURE (2008)
Vaccinia virus proteins A52 and B14 share a Bcl-2-like fold but have evolved to inhibit NF-κB rather than apoptosis
Stephen C. Graham et al.
PLOS PATHOGENS (2008)
The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy
D. Y. Lee et al.
ONCOGENE (2008)
BH3 domains define selective inhibitory interactions with BHRF-1 and KSHVBCL-2
A. M. Flanagan et al.
CELL DEATH AND DIFFERENTIATION (2008)
LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1
Julia Rastelli et al.
BLOOD (2008)
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma
E. Anderton et al.
ONCOGENE (2008)
Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus-encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells
Joanne R. Flavell et al.
BLOOD (2008)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
Epstein-Barr virus (EBV)-Encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-Induced B-Cell growth transformation
Yi Wu et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication
Li Xing et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/P13-K/Akt pathway
Makoto Fukuda et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-Cell specificity of its growth-transforming program
Rosemary Tierney et al.
JOURNAL OF VIROLOGY (2007)
Truncated form of the Epstein-Barr virus protein EBNA-LP protcts against caspase-dependent apoptosis by inhibiting protein phosphatase 2A
Julie Garibal et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways
V. H. J. Wood et al.
ONCOGENE (2007)
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein
Samantha Cooray et al.
JOURNAL OF GENERAL VIROLOGY (2007)
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax
G. Bellot et al.
CELL DEATH AND DIFFERENTIATION (2007)
Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein
Mika Aoyagi et al.
PROTEIN SCIENCE (2007)
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes
Wangrong Wen et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells
Seiji Maruo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells
Gemma L. Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays
Andrew I. Bell et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBFI/RBPJκ-Dependent pathway
Pamela M. Pegman et al.
JOURNAL OF VIROLOGY (2006)
A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses
A Grundhoff et al.
RNA (2006)
Virus and cell RNAs expressed during Epstein-Barr virus replication
J Yuan et al.
JOURNAL OF VIROLOGY (2006)
EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1:: role of NF-κB, STAT1, and p53
C Le Clorennec et al.
BLOOD (2006)
Epstein-Barr virus MicroRNAs are evolutionarily conserved and differentially expressed
Xuezhong Cai et al.
PLOS PATHOGENS (2006)
Rescue of crippled germinal center B cells from apoptosis by Epstein-Barr virus
C Mancao et al.
BLOOD (2005)
Epstein-Barr virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis
M Altmann et al.
PLOS BIOLOGY (2005)
Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth
C Shannon-Lowe et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Epstein-Baff virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies
G Cabras et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas
C Bellan et al.
BLOOD (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation
M Yajima et al.
JOURNAL OF VIROLOGY (2005)
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1: Implications for EBV-mediated immortalization
V Saridakis et al.
MOLECULAR CELL (2005)
Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1
M Nasimuzzaman et al.
MOLECULAR THERAPY (2005)
Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro
A Chen et al.
JOURNAL OF VIROLOGY (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein
E Kashuba et al.
EXPERIMENTAL CELL RESEARCH (2005)
Identification of virus-encoded microRNAs
S Pfeffer et al.
SCIENCE (2004)
Bim is a suppressor of Myc-induced mouse B cell leukemia
A Egle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Latent membrane protein 2A inhibits transforming growth factor-β1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway
M Fukuda et al.
JOURNAL OF VIROLOGY (2004)
Nuclear factor κB-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor
BN D'Souza et al.
JOURNAL OF VIROLOGY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors
G DiPerna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The amino terminus of Epstein-Barr virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes
J Sears et al.
JOURNAL OF VIROLOGY (2004)
EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli
JM Lee et al.
JOURNAL OF VIROLOGY (2004)
BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function
TE Morrison et al.
VIROLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Epstein-Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
M Luftig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
G Kennedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders
J van Beek et al.
JOURNAL OF GENERAL VIROLOGY (2003)
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL
KH Maclean et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells
E Kashuba et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1
G Matsuda et al.
MICROBIOLOGY AND IMMUNOLOGY (2003)
c-MYC: More than just a matter of life and death
S Pelengaris et al.
NATURE REVIEWS CANCER (2002)
Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2
G Kelly et al.
NATURE MEDICINE (2002)
Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells
M Kawanishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Epstein-Barr virus EBNA2 blocks Nur77-mediated apoptosis
JM Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
c-Myc functionally cooperates with Bax to induce apoptosis
P Juin et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi
SA Xue et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins
DS Bellows et al.
JOURNAL OF VIROLOGY (2002)
LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways
M Merchant et al.
VIROLOGY (2001)
Apoptosis triggered by Myc-induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis
CM Eischen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Spl and Sp3 binding sites
T Ragoczy et al.
JOURNAL OF VIROLOGY (2001)
The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis
R Benetti et al.
EMBO JOURNAL (2001)
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
MS Lindström et al.
ONCOGENE (2001)
Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC
JX Zhang et al.
JOURNAL OF VIROLOGY (2001)
Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death
GJ Inman et al.
JOURNAL OF VIROLOGY (2001)
Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells
H Höfelmayr et al.
JOURNAL OF VIROLOGY (2001)
An Epstein-Barr virus protein interacts with Notch
S Kusano et al.
JOURNAL OF VIROLOGY (2001)
Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway
R Swart et al.
JOURNAL OF VIROLOGY (2000)
Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis
IK Ruf et al.
JOURNAL OF VIROLOGY (2000)
The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line
B D'Souza et al.
JOURNAL OF VIROLOGY (2000)
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus
PR Smith et al.
JOURNAL OF VIROLOGY (2000)
Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2
LJ Strobl et al.
JOURNAL OF VIROLOGY (2000)
分享论文
